Drug intelligence / Profile preview

Vismed Gel Multi

Development stage
Unknown
Lead developer
TRB Chemedica
Administration
Ophthalmic
01

Overview

Vismed Gel Multi is a preservative-free, multidose ophthalmic hydrogel containing 0.3% sodium hyaluronate formulated as a hypotonic solution with essential tear ions to provide sustained lubrication of the ocular surface in patients with dry eye symptoms and ocular surface damage, including those with superficial keratitis, Sjögren syndrome, or primary dry eye syndrome.[3][4][5][7][9][11][13] Sodium hyaluronate, a viscoelastic, water-retaining polymer naturally present in the eye, forms a stable coating on the cornea and conjunctiva that is slowly eliminated by blinking, delivering long-lasting relief of dryness, burning, ocular fatigue, and irritation from environmental stress or contact lens wear, and is suitable for use with both rigid and soft lenses.[3][4][5][7][9][11][13] The product is supplied in a 10 ml multidose container with a reproducible drop delivery system and is used as needed, typically 1–2 drops per dose, as an over-the-counter lubricant eye drop rather than a systemically active pharmaceutical agent.[2][5][8][11][15][16]

Brand names
Vismed Gel Multi
Other names
VISMEDsodium hyaluronate 0.3% ophthalmic gelhyaluronic acid ophthalmic gel
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Vismed Gel Multi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vismed Gel Multi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call